07:00 , Jun 12, 2000 |  BC Week In Review  |  Company News

Apoptogen, Exogen Neuro deal

The companies merged to form AEgera Therapeutics Inc. (Montreal), which is developing treatments for neurological disorders and cancer. Exogen has been focused on the identification and control of cellular pathways influencing neuronal survival, growth and...
07:00 , Jun 6, 2000 |  BC Extra  |  Company News

Apoptogen and Exogen merge

Apoptogen (Ottawa, Ontario) and Exogen Neurosciences (Montreal, Quebec) merged to form AEgera Therapeutics (Montreal), which is developing treatments for neurological disorders and cancer. Exogen has been focused on the identification and control of cellular pathways...
07:00 , Jun 28, 1999 |  BC Week In Review  |  Company News

Apoptogen other research news

Apoptogen researchers and colleagues published in Nature Cell Biology the discovery of an internal ribosome entry site (IRES) sequence in XIAP's mRNA. The IRES enables translation of XIAP protein under conditions of cellular stress while...
07:00 , Aug 31, 1998 |  BioCentury  |  Emerging Company Profile

TerraGen Diversity Inc.

TerraGen Diversity Inc. Vancouver, B.C. Technology: Compound discovery by isolation of genomic DNA from uncultivable microorganisms Disease focus: Infectious diseases and cancer Clinical status: Preclinical Founded: 1996 by Julian Davies, the University of British Columbia...
07:00 , May 11, 1998 |  BC Week In Review  |  Company News

Kinetek board of directors update

Kinetek Pharmaceuticals Inc., Vancouver, B.C.   Business: Cancer, Metabolic, Drug discovery   Appointed: John Gillard, president and COO of ApoptoGen Inc., as chairman, formerly a director  ...
08:00 , Nov 3, 1997 |  BC Week In Review  |  Clinical News

Apoptogen preclinical data

Researchers presented data suggesting that a gene therapy system delivering NAIP to brain cells has therapeutic value in animal models of Parkinson's. At the Society for Neuroscience Meeting in New Orleans, the scientists presented data...
07:00 , Sep 8, 1997 |  BC Week In Review  |  Company News

Apoptogen other research news

Apoptogen and collaborators published data in Nature Medicine showing that increased expression of NAIP prevented death of brain cells in a rat model of stroke. The company plans to explore both gene therapy and small...
07:00 , Sep 8, 1997 |  BioCentury  |  Tools & Techniques

Hoist on its own petard;

Two papers in last week's Cell demonstrate that HIV's mode of entry into T cells can be turned against it. HIV enters T cells by binding to the coreceptors CD4 and CXCR4 . After internalization...